(Total Views: 730)
Posted On: 10/16/2020 1:13:45 AM
Post# of 72445
Re: annakneemuss #66865
This is the conclusion paragraph from the medRxiv preprint server dated 10/15/20:
CONCLUSIONS These Remdesivir, Hydroxychloroquine, Lopinavir and Interferon regimens appeared to have little or no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation and duration of hospital stay. The mortality findings contain most of the randomized evidence on Remdesivir and Interferon, and are consistent with meta-analyses of mortality in all major trials.
————
Once Brilacidin gets to human trials IMO it will easily hurdle a very low bar set for CV19 antiviral therapies.
CONCLUSIONS These Remdesivir, Hydroxychloroquine, Lopinavir and Interferon regimens appeared to have little or no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation and duration of hospital stay. The mortality findings contain most of the randomized evidence on Remdesivir and Interferon, and are consistent with meta-analyses of mortality in all major trials.
————
Once Brilacidin gets to human trials IMO it will easily hurdle a very low bar set for CV19 antiviral therapies.
(10)
(0)
